Sign in

CIK 0001501989

  • Accelerated filer

CytomX Therapeutics, Inc.

Sign in to watch
Ticker
CTMX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
273521219
Phone
+1 650-515-3185
Business address
151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Open-market sale Chief Medical Officer sold 5,602 shares at $1.42 ($7,965)
  2. 4 Open-market sale Chief Financial Officer sold 3,949 shares at $1.42 ($5,617)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Option exercise President and CEO acquired 90,931 shares (option exercise)
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 4 Grant or award EVP, Chief Development Officer acquired 40,000 shares (grant or award)
  14. 4 Grant or award General Counsel acquired 22,500 shares (grant or award)
  15. 4 Grant or award Chief Medical Officer acquired 22,500 shares (grant or award)
  16. 4 Grant or award Chief Financial Officer acquired 22,500 shares (grant or award)
  17. 4 Grant or award President and CEO acquired 75,000 shares (grant or award)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 7 of 20 · 400 filings